Plus   Neg

Stock Alert: Daqo New Energy Touches New 52-week High

Shares of Daqo New Energy Corp. (DQ), a China-based manufacturer of polysilicon for the global photovoltaic or PV industry, are rising almost 4 percent or $3.10 in Friday's morning trade at $82.88, after hitting a new 52-week high of $84.58 despite no company-centric news.

U.S. stocks are rising on Friday despite the release of a closely watched Labor Department report showing an unexpected decrease in U.S. employment in the month of December. Investors remain optimistic that a Democrat-controlled government will lead to more fiscal stimulus and a better handling of the coronavirus vaccine rollout.

Daqo New Energy has traded in a range of $8.32 to $84.58 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Editors Pick
United Airlines is adding three new flights to Croatia, Greece and Iceland, which are starting to reopen to vaccinated visitors. The move would give travelers more options for summer travel by flying direct to these countries. Last month's searches on United.com for flights to Croatia, Greece and Iceland were up 61 percent. Johnson & Johnson's (JNJ) Covid-19 vaccine is expected to be back on track as early as this weekend as a decision is expected after the advisory panel meeting of the U.S. Centers for Disease Control and Prevention (CDC) slated on April 23, according to Dr. Anthony Fauci, the chief medical adviser to President Joe Biden. MK-4482, the experimental antiviral drug for COVID-19, showed promise to prevent and treat SARS-CoV-2 infection in hamster study, according to the scientists of National Institutes of Health or NIH. The drug significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection. MK-4482, delivered orally, is now in Phase 2 and 3 human clinical studies.
Follow RTT